David M. Roy
AstraZeneca (Japan)(JP)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Bone health and treatments, Cancer Genomics and Diagnostics, Bone and Joint Diseases, Tumors and Oncological Cases
Most-Cited Works
- → The mutational landscape of adenoid cystic carcinoma(2013)455 cited
- → High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy(2007)80 cited
- → Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations(2016)59 cited
- → Local Mesenchymal Stem/Progenitor Cells Are a Preferential Target for Initiation of Adult Soft Tissue Sarcomas Associated with p53 and Rb Deficiency(2010)45 cited
- → RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch(2014)44 cited
- → Dapsone-Induced Methemoglobinemia after Hematopoietic Stem Cell Transplantation(2006)13 cited
- → High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.(2005)3 cited
- → Abstract LB-169: Multidimensional genomic dissection of chromosome 9p in glioma(2015)
- → Prognostic value of PORTEC-3 molecular markers by disease risk in a real-world early endometrial cancer cohort.(2024)
- → Abstract 4183: Modeling soft tissue sarcomas by conditional inactivation of p53 and Rb tumor suppressor genes(2010)